Mupirocin and Mupirocin Calcium API Producers and Mupirocin and Mupirocin Calcium API Market Trend

Mupirocin is an anti-bacterial ointment used to treat superficial skin infections such as impetigo caused due to bacteria such as Staphylococcus aureus and Streptococcus pyogenes.

The global Mupirocin and Mupirocin Calcium API market size was USD 36.8 million in 2017, growing to USD 45.3 million in 2022, with a CAGR of 4.2% from 2017 to 2022. The global Mupirocin and Mupirocin Calcium API market size is expected to reach USD 59.0 million in 2027, with a CAGR of 5.4% from 2022 to 2027.

Figure 2017-2027 Global Mupirocin and Mupirocin Calcium API Market Size (Million USD) and CAGR

Mupirocin and Mupirocin Calcium API suppliers include Concord Biotech, Huadong Medicine, Teva, Bills Biotech, Fishfa BioGenics, and Samex Overseas etc.

Currently, APAC is the largest Mupirocin and Mupirocin Calcium API consumption region accounting for 46% volume share, followed by comparable consumption in North America and Europe markets accounting for 27% and 16% volume share respectively.